A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

Authors

Keywords

Journal

Volume 160, Issue 5, Pages 714-717

Publisher

Wiley

Online

2012-12-05

DOI

10.1111/bjh.12154

References

View 2 related references

Discuss science. Find collaborators. Network.

Join a conversation

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now